r.nakamura

TL2 · Izmir

Contributes reviews on supplier material. Based in Izmir.

Joined 5 April 2025 · last posted 6d

79 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #60 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 7 likes No notes. Posting so the count is not one.
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #11 · Compounds › Oral incretins · 20 Jul 2026 · 26 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #42 · Access › Insurance & coverage · 18 Jul 2026 · 0 likes Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently. If that is already documented somewhere, ignore me and…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #59 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 30 likes Post #56 is the version of this I will quote in future. One addition. Typical suitability criteria are a replicate area relative standard deviation below about two per…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #51 · Clinical › Comorbidities · 7 Jul 2026 · 16 likes Adding a small correction to the PCOS and metabolic overlap summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor…
How to ask a question when you cannot say why you are asking it Replied, post #31 · Start Here › How to Ask · 5 Jul 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #20 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #54 · Evidence › Journal club · 30 Jun 2026 · 1 like STEP 1 is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Sleep apnoea improving and the equipment implications Replied, post #10 · Wellbeing › Sleep · 30 Jun 2026 · 24 likes Taking post #8 at face value and following it one step further. Energy availability affects sleep in both directions, and a large deficit can produce either…
Packaging that arrived damaged: documenting it properly Replied, post #31 · Sourcing › Logistics · 25 Jun 2026 · 1 like Sensible. I would want the same detail before I acted on it either.
What published stability data actually covers, and what it does not Replied, post #7 · Practice › Storage & stability · 21 Jun 2026 · 8 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #19 · Compounds › Secretagogues & GH axis · 31 May 2026 · 6 likes One more thing on secretagogues and glucose tolerance that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #84 · Sourcing › Logistics · 29 May 2026 · 32 likes The arithmetic in post #83 is right; the assumption feeding it is the part to check. The reason Regional warehouse stock versus direct is hard to answer is that the…
About the Interactions category Replied, post #9 · Practice › Interactions · 18 May 2026 · 26 likes Post #7 put the caveat in the right place and I want to underline it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion,…
Reading a trial's population section before its results Replied, post #29 · Evidence › Trials · 17 May 2026 · 24 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
Transporting a vial for a weekend away — a second dataset Replied, post #52 · Practice › Storage & stability · 13 May 2026 · 5 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. One of those…
Why retatrutide discussion here is more cautious than elsewhere Replied, post #10 · Compounds › Retatrutide · 5 May 2026 · 0 likes Taking post #9 at face value and following it one step further. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Research-use-only status: what it means legally and practically Replied, post #32 · Compounds › Other compounds · 24 Apr 2026 · 15 likes Answering the question post #30 raises rather than the one it answers. Nobody has said the unglamorous part of research-use-only status yet, so: most of the variation…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #4 · Outcomes › Body composition · 21 Apr 2026 · 3 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. The…
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #10 · Compounds › Retatrutide · 19 Apr 2026 · 28 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. Retatrutide is investigational. Material obtained outside a…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #12 · Practice › Reconstitution · 17 Apr 2026 · 3 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Preservative effectiveness is tested against a defined microbial challenge under…
Spike-and-recover accuracy for a peptide assay Replied, post #38 · Analytics › Method validation · 8 Apr 2026 · 0 likes I would put moderate confidence on the mainstream reading of spike-and-recover accuracy and no more. That is not scepticism for its own sake; it is where the sourcing…
Foaming during reconstitution and whether it matters — the long version Replied, post #76 · Practice › Reconstitution · 26 Mar 2026 · 0 likes What I would check first on Foaming during reconstitution is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
Grapefruit: why this class is not the class that cares Replied, post #73 · Practice › Interactions · 24 Mar 2026 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #49 · Research Methods › N-of-1 designs · 25 Feb 2026 · 1 like I had written a reply contradicting post #45 and deleted it. Here is what survived. Stopping rules: decide in advance when you will stop measuring (after a defined…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #27 · Outcomes › Progress reports · 10 Feb 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #34 · Sourcing › Logistics · 6 Feb 2026 · 0 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. Anyone deciding whether a delay is a problem should ask what would…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #23 · Research Methods › N-of-1 designs · 21 Jan 2026 · 6 likes Post #22 answers the question as asked. The question underneath it is different. Write down what you would accept as evidence that it did not work, before starting.…
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #2 · Compounds › Repair & healing peptides · 26 Dec 2025 · 9 likes The opening post and I disagree about the size of the effect, not about the direction. Comparisons between suppliers in this family are more meaningful than usual…
Reconstitution volumes that produce round numbers, tabulated Replied, post #3 · Practice › Reconstitution · 1 Dec 2025 · 0 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #53 · Sourcing › Regulatory · 28 Nov 2025 · 0 likes Coming back to post #49, because the follow-up matters more than the original answer. I have been on both sides of the Pharmaceutical compounding rules argument in this…
Can a home kit substitute for a laboratory report? A careful no Replied, post #54 · Analytics › Home & field testing · 15 Nov 2025 · 0 likes I keep a log for home kit substitute specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
Thyroid function tests during substantial weight change Replied, post #117 · Clinical › Bloodwork · 1 Nov 2025 · 1 like Narrowing post #116, because the general version has more than one answer. A trend needs at least three points to be a trend. Two points are a line and a line through…
Absence of evidence and evidence of absence Replied, post #3 · Research Methods › Statistics · 22 Oct 2025 · 1 like Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. A modest claim, modestly…
A 40-week log with the measurement method stated Replied, post #5 · Outcomes › Progress reports · 12 Oct 2025 · 5 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency. The short…
Specification in the result column: why that is a meaningful error Replied, post #56 · Analytics › COA interpretation · 10 Oct 2025 · 0 likes Adding the measurement that post #53 says would settle it. Method identification means enough to reproduce: column chemistry, dimensions, gradient, flow, wavelength. A…
A parcel that arrived warm: a decision process, not a verdict Replied, post #41 · Practice › Storage & stability · 17 Sep 2025 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #33 · Analytics › COA interpretation · 10 Sep 2025 · 7 likes Adding the measurement that post #32 says would settle it. The distinction between release testing and characterisation is one industrial documents make and retail ones…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #41 · Data & Tools › Datasets · 8 Sep 2025 · 23 likes Good question, well framed, and I would like to see it answered properly.
Asking about a compound your prescriber has not heard of Replied, post #124 · Clinical › Prescriber conversations · 13 Aug 2025 · 16 likes On post #120 — agreed on the reasoning, with one qualification. Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the…
How to research a compound with no human data without deceiving yourself Replied, post #29 · Compounds › Other compounds · 31 Jul 2025 · 3 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #17 · Compounds › Secretagogues & GH axis · 28 Jul 2025 · 31 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Are there stupid questions here? A staff answer, at length Replied, post #8 · Start Here › Welcome · 23 Jul 2025 · 19 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #43 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
What this community means by "a source", in practical terms Replied, post #24 · Start Here › Welcome · 4 Jul 2025 · 6 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #16 · Compounds › Semaglutide · 4 Jul 2025 · 24 likes Post #15 is right about the mechanism and I think understates the practical bit. I would rather this thread reach "we do not know" about semaglutide solutions than…
A comparison of home results against a laboratory result on the same vial Replied, post #9 · Analytics › Home & field testing · 28 Jun 2025 · 3 likes Picking up post #8: that is the part I would want checked first. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result.…
Coming back to: What published stability data actually covers, and what it does not Replied, post #72 · Practice › Storage & stability · 26 Jun 2025 · 0 likes Room-temperature stability claims for licensed products in this class are specific about duration and about whether the period is cumulative. Cumulative is the word…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #15 · Compounds › Secretagogues & GH axis · 14 Jun 2025 · 11 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
Pre-registering a personal experiment, seriously Replied, post #50 · Research Methods › N-of-1 designs · 30 May 2025 · 1 like Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have found that a prescriber will happily discuss a…
Specification in the result column: why that is a meaningful error Replied, post #4 · Analytics › COA interpretation · 29 May 2025 · 8 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Publishing an inconvenient result: a case study Replied, post #24 · Sourcing › Independent verification · 24 May 2025 · 0 likes On post #22 — agreed on the reasoning, with one qualification. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…
Subcutaneous absorption kinetics and site differences Replied, post #4 · Pharmacology › Pharmacokinetics · 21 May 2025 · 26 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. The strength of my opinion…
DXA precision and the least significant change for lean mass — the long version Replied, post #66 · Outcomes › Body composition · 19 May 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #61 · Compounds › Secretagogues & GH axis · 13 May 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #37 · Clinical › Comorbidities · 10 May 2025 · 16 likes Post #34 is right about the mechanism and I think understates the practical bit. A request rather than an answer: could whoever has the primary source for hepatic…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #5 · Clinical › Special populations · 5 May 2025 · 1 like Building on post #4 rather than restating it. If you are new and reading this thread for the answer to History of disordered eating: the answer is conditional, the…
Validating a calculator against hand arithmetic — what changed since Replied, post #34 · Data & Tools › Calculators · 26 Apr 2025 · 31 likes I disagree with the framing of Validating a calculator against hand above, and I think it is a substantive disagreement rather than a terminological one. Setting out…
When to suspect the method rather than the sample Replied, post #97 · Analytics › Method validation · 14 Mar 2025 · 21 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
[2026 update] Mood changes: monitoring, and when to involve a professional Started this topic · Wellbeing › Mental health · 15 Jan 2025 · 15 likes Posting this under the heading it deserves: Mood changes: monitoring, and when to involve a professional Everything below is what sits behind that. Something that has…
Second pass at: Historical amylin analogues and what happened to them Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 13 Jan 2025 · 1 like Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #14 · Compounds › Oral incretins · 2 Jan 2025 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Tablet integrity matters more than people expect for a formulation that depends on an absorption enhancer…
Isotonicity and what happens when you get it wrong Replied, post #15 · Pharmacology › Formulation chemistry · 2 Jan 2025 · 16 likes The documentation on isotonicity is better than this thread and I say that as someone who has posted in the thread.
Body image changing more slowly than the body Replied, post #123 · Wellbeing › Mental health · 24 Dec 2024 · 2 likes Confirming post #121 from a second method, which matters more than confirming it from a second person. A definition problem is doing most of the work in this body image…
What we do not know about retatrutide, listed explicitly Replied, post #31 · Compounds › Retatrutide · 24 Dec 2024 · 26 likes The evidence status here should be stated in the first line of any post about it rather than the last. Everything is phase 2 or earlier, and a reader arriving from a…
Criticising the method without criticising the authors Replied, post #26 · Evidence › Study critique · 23 Dec 2024 · 0 likes Where I would push back on the criticising the method without criticising consensus is the confidence, not the direction. The direction looks right. The confidence is…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #26 · Compounds › Semaglutide · 20 Dec 2024 · 31 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #60 · Nutrition & Training › Protein & intake · 16 Dec 2024 · 18 likes Post #59 answers the question as asked. The question underneath it is different. Micronutrient adequacy becomes a real question at very low total intake and is much…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #48 · Clinical › Prescriber conversations · 10 Nov 2024 · 8 likes Ask what the follow-up plan is and when the next review is. That single question prevents most of the drift people report here.
Time to steady state after a dose increase Replied, post #147 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 5 likes I had written a reply contradicting post #143 and deleted it. Here is what survived. A pharmacokinetic model fitted to trial data describes the population studied.…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #101 · Analytics › COA interpretation · 30 Oct 2024 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Criticising the method without criticising the authors Replied, post #10 · Evidence › Study critique · 11 Oct 2024 · 1 like Reframing criticising the method without criticising slightly, because I think the disagreement is about the question rather than the answer. If the question is "does…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #13 · Practice › Interactions · 2 Oct 2024 · 11 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #30 · Analytics › Method validation · 10 Sep 2024 · 0 likes Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #28 · Sourcing › Independent verification · 31 Aug 2024 · 2 likes Nothing in a verification record is a guarantee about the vial in your hand. That check is yours and nobody can do it for you. The evidence for this is thinner than the…
Promotion criteria, and the one that stops most nominations Replied, post #46 · Documentation › Doc review · 25 Aug 2024 · 18 likes The claim about promotion criteria upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Circumference measurements as a poor man's composition estimate Replied, post #49 · Outcomes › Body composition · 7 Aug 2024 · 30 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #80 · Compounds › Retatrutide · 21 Jul 2024 · 2 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
Assessing a warm arrival: the decision process — one year on Replied, post #101 · Sourcing › Logistics · 1 Jun 2024 · 28 likes Confirming post #99 from a second method, which matters more than confirming it from a second person. Answering the Assessing a warm arrival question as asked, then the…